Exploiting microRNAs for cell engineering and therapy

Biotechnology Advances

Volumn 30, Issue 3, 2012, Pages 753-765

  Bratkovič, Tomaž ^a   Glavan, Gordana ^a   Štrukelj, Borut ^a   Živin, Marko ^a   Rogelj, Boris ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Biogenesis; Cell engineering; Function; MicroRNA; Therapy

Indexed keywords

BIOGENESIS; LABORATORY STUDIES; LARGE CLASS; MICRORNAS; NON-CODING RNAS; PHENOTYPIC TRAITS; PROTEIN-CODING GENES; THERAPY; UNTRANSLATED REGIONS;

BIOINFORMATICS; CELL ENGINEERING; FUNCTIONS; GENE EXPRESSION; MOLECULAR BIOLOGY; NUCLEIC ACIDS;

GENE EXPRESSION REGULATION;

MICRORNA; PROTEIN; RECOMBINANT PROTEIN;

BIOENGINEERING; BIOINFORMATICS; CELL ORGANELLE; DATA SET; DISEASE TREATMENT; GENE EXPRESSION; PHENOTYPIC PLASTICITY; PROTEIN; RNA;

CELL DIFFERENTIATION; CELL ENGINEERING; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; REVIEW; TRANSGENE;

CELL DIFFERENTIATION; CELL ENGINEERING; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; PROTEINS; RECOMBINANT PROTEINS; TRANSGENES;

EUKARYOTA;

EID: 84857505891     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.01.006     Document Type: Review

References (178)

1. Abrahante J.E., Daul A.L., Li M., Volk M.L., Tennessen J.M., Miller E.A., et al. The Caenorhabditis elegans hunchback-like gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs. Dev Cell 2003, 4:625-637.
2. Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs. J Mol Med (Berl) 2011, 89:445-457.
3. Alevizos I., Illei G.G. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 2010, 6:391-398.
4. Amarzguioui M., Rossi J.J., Kim D. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Lett 2005, 579:5974-5981.
5. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
6. Andrei M.A., Ingelfinger D., Heintzmann R., Achsel T., Rivera-Pomar R., Luhrmann R. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA 2005, 11:717-727.
7. Anokye-Danso F., Trivedi C.M., Juhr D., Gupta M., Cui Z., Tian Y., et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8:376-388.
8. Aravin A., Tuschl T. Identification and characterization of small RNAs involved in RNA silencing. FEBS Lett 2005, 579:5830-5840.
9. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
10. Barnes D., Kunitomi M., Vignuzzi M., Saksela K., Andino R. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 2008, 4:239-248.
11. Barron N., Kumar N., Sanchez N., Doolan P., Clarke C., Meleady P., et al. Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7. J Biotechnol 2011, 151:204-211.
12. Barron N., Sanchez N., Kelly P., Clynes M. MicroRNAs: tiny targets for engineering CHO cell phenotypes?. Biotechnol Lett 2011, 33:11-21.
13. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004, 5:396-400.
14. Behm-Ansmant I., Rehwinkel J., Doerks T., Stark A., Bork P., Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev 2006, 20:1885-1898.
15. Benes V., Castoldi M. Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Methods 2010, 50:244-249.
16. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
17. Bernstein E., Caudy A.A., Hammond S.M., Hannon G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001, 409:363-366.
18. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Stress-induced reversal of microRNA repression and mRNA P-body localization in human cells. Cold Spring Harb Symp Quant Biol 2006, 71:513-521.
19. Boehm M., Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science 2005, 310:1954-1957.
20. Bohnsack M.T., Czaplinski K., Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004, 10:185-191.
21. Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., Memeo L., et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008, 14:1271-1277.
22. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol 2006, 13:1097-1101.
23. Boutz P.L., Chawla G., Stoilov P., Black D.L. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev 2007, 21:71-84.
24. Bratkovič T., Rogelj B. Biology and applications of small nucleolar RNAs. Cell Mol Life Sci 2011, 68:3843-3851.
25. Brodersen P., Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 2009, 10:141-148.
26. Brown B.D., Naldini L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat Rev Genet 2009, 10:578-585.
27. Brown B.D., Cantore A., Annoni A., Sergi L.S., Lombardo A., Della Valle P., et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 2007, 110:4144-4152.
28. Brown B.D., Gentner B., Cantore A., Colleoni S., Amendola M., Zingale A., et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007, 25:1457-1467.
29. Burroughs A.M., Ando Y., de Hoon M.J., Tomaru Y., Suzuki H., Hayashizaki Y., et al. Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin. RNA Biol 2011, 8:158-177.
30. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99:15524-15529.
31. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004, 101:2999-3004.
32. Cammarata G., Augugliaro L., Salemi D., Agueli C., La Rosa M., Dagnino L., et al. Differential expression of specific microRNA and their targets in acute myeloid leukemia. Am J Hematol 2010, 85:331-339.
33. Card D.A., Hebbar P.B., Li L., Trotter K.W., Komatsu Y., Mishina Y., et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008, 28:6426-6438.
34. Caygill E.E., Johnston L.A. Temporal regulation of metamorphic processes in Drosophila by the let-7 and miR-125 heterochronic microRNAs. Curr Biol 2008, 18:943-950.
35. Chan E., Prado D.E., Weidhaas J.B. Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol Med 2011, 17:235-243.
36. Chang S., Johnston R.J., Hobert O. A transcriptional regulatory cascade that controls left/right asymmetry in chemosensory neurons of C. elegans. Genes Dev 2003, 17:2123-2137.
37. Chang S., Johnston R.J., Frokjaer-Jensen C., Lockery S., Hobert O. MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode. Nature 2004, 430:785-789.
38. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233.
39. Chen J.F., Callis T.E., Wang D.Z. microRNAs and muscle disorders. J Cell Sci 2009, 122:13-20.
40. Chendrimada T.P., Finn K.J., Ji X., Baillat D., Gregory R.I., Liebhaber S.A., et al. MicroRNA silencing through RISC recruitment of eIF6. Nature 2007, 447:823-828.
41. Clarke C., Doolan P., Barron N., Meleady P., O'Sullivan F., Gammell P., et al. Large scale microarray profiling and coexpression network analysis of CHO cells identifies transcriptional modules associated with growth and productivity. J Biotechnol 2011, 155:350-359.
42. Clarke C., Doolan P., Barron N., Meleady P., O'Sullivan F., Gammell P., et al. Predicting cell-specific productivity from CHO gene expression. J Biotechnol 2011, 151:159-165.
43. Czech B., Hannon G.J. Small RNA sorting: matchmaking for Argonautes. Nat Rev Genet 2011, 12:19-31.
44. Davis-Dusenbery B.N., Hata A. Mechanisms of control of microRNA biogenesis. J Biochem 2010, 148:381-392.
45. Derry M.C., Yanagiya A., Martineau Y., Sonenberg N. Regulation of poly(A)-binding protein through PABP-interacting proteins. Cold Spring Harb Symp Quant Biol 2006, 71:537-543.
46. Doench J.G., Petersen C.P., Sharp P.A. siRNAs can function as miRNAs. Genes Dev 2003, 17:438-442.
47. Dugas D.V., Bartel B. MicroRNA regulation of gene expression in plants. Curr Opin Plant Biol 2004, 7:512-520.
48. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 2011, 44:839-847.
49. Ebert M.S., Neilson J.R., Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 2007, 4:721-726.
50. Elbashir S.M., Lendeckel W., Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001, 15:188-200.
51. Erson A.E., Petty E.M. MicroRNAs in development and disease. Clin Genet 2008, 74:296-306.
52. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006, 3:87-98.
53. Estep M., Armistead D., Hossain N., Elarainy H., Goodman Z., Baranova A., et al. Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2010, 32:487-497.
54. Eulalio A., Rehwinkel J., Stricker M., Huntzinger E., Yang S.F., Doerks T., et al. Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing. Genes Dev 2007, 21:2558-2570.
55. Eulalio A., Huntzinger E., Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008, 132:9-14.
56. Farh K.K., Grimson A., Jan C., Lewis B.P., Johnston W.K., Lim L.P., et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005, 310:1817-1821.
57. Fichtlscherer S., Zeiher A.M., Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?. Arterioscler Thromb Vasc Biol 2011, 31:2383-2390.
58. Fontana L., Fiori M.E., Albini S., Cifaldi L., Giovinazzi S., Forloni M., et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008, 3:e2236.
59. Gallagher I.J., Scheele C., Keller P., Nielsen A.R., Remenyi J., Fischer C.P., et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med 2010, 2:9.
60. Gammell P., Barron N., Kumar N., Clynes M. Initial identification of low temperature and culture stage induction of miRNA expression in suspension CHO-K1 cells. J Biotechnol 2007, 130:213-218.
61. Gao J., Wang W.Y., Mao Y.W., Graff J., Guan J.S., Pan L., et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466:1105-1109.
62. Gauthier B.R., Wollheim C.B. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat Med 2006, 12:36-38.
63. Gentner B., Schira G., Giustacchini A., Amendola M., Brown B.D., Ponzoni M., et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 2009, 6:63-66.
64. Gorospe M., Abdelmohsen K. MicroRegulators come of age in senescence. Trends Genet 2011, 27:233-241.
65. Griffiths-Jones S. miRBase: the microRNA sequence database. Methods Mol Biol 2006, 342:129-138.
66. Gu S., Kay M.A. How do miRNAs mediate translational repression?. Silence 2010, 1:11.
67. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010, 17:193-199.
68. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010, 127:118-126.
69. Huangfu D., Osafune K., Maehr R., Guo W., Eijkelenboom A., Chen S., et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008, 26:1269-1275.
70. Humphreys D.T., Westman B.J., Martin D.I., Preiss T. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 2005, 102:16961-16966.
71. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
72. Ji Q., Hao X., Meng Y., Zhang M., Desano J., Fan D., et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008, 8:266.
73. Jinek M., Doudna J.A. A three-dimensional view of the molecular machinery of RNA interference. Nature 2009, 457:405-412.
74. Johnson K.C., Jacob N.M., Nissom P.M., Hackl M., Lee L.H., Yap M., et al. Conserved microRNAs in Chinese hamster ovary cell lines. Biotechnol Bioeng 2011, 108:475-480.
75. Johnston R.J., Hobert O. A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature 2003, 426:845-849.
76. Jopling C.L. Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans 2008, 36:1220-1223.
77. Judson R.L., Babiarz J.E., Venere M., Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 2009, 27:459-461.
78. Kai Z.S., Pasquinelli A.E. MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nat Struct Mol Biol 2010, 17:5-10.
79. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
80. Kinch L.N., Grishin N.V. The human Ago2 MC region does not contain an eIF4E-like mRNA cap binding motif. Biol Direct 2009, 4:2.
81. Kiriakidou M., Tan G.S., Lamprinaki S., De Planell-Saguer M., Nelson P.T., Mourelatos Z. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 2007, 129:1141-1151.
82. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006, 11:441-450.
83. Koscianska E., Baev V., Skreka K., Oikonomaki K., Rusinov V., Tabler M., et al. Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Mol Biol 2007, 8:79.
84. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
85. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
86. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
87. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
88. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
89. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23:4051-4060.
90. Lesterhuis W.J., Haanen J.B., Punt C.J. Cancer immunotherapy-revisited. Nat Rev Drug Discov 2011, 10:591-600.
91. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
92. Li W., Ruan K. MicroRNA detection by microarray. Anal Bioanal Chem 2009, 394:1117-1124.
93. Li M., Marin-Muller C., Bharadwaj U., Chow K.H., Yao Q., Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J Surg 2009, 33:667-684.
94. Li L., Xu J., Yang D., Tan X., Wang H. Computational approaches for microRNA studies: a review. Mamm Genome 2010, 21:1-12.
95. Lin S.L. Concise review: deciphering the mechanism behind induced pluripotent stem cell generation. Stem Cells 2011, 29:1645-1649.
96. Lin S.Y., Johnson S.M., Abraham M., Vella M.C., Pasquinelli A., Gamberi C., et al. The C. elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev Cell 2003, 4:639-650.
97. Lin S.L., Chang D.C., Chang-Lin S., Lin C.H., Wu D.T., Chen D.T., et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 2008, 14:2115-2124.
98. Lin N., Davis A., Bahr S., Borgschulte T., Achtien K., Kayser K. Profiling highly conserved microrna expression in recombinant IgG-producing and parental chinese hamster ovary cells. Biotechnol Prog 2010, 27:1163-1171.
99. Lin S.L., Chang D.C., Lin C.H., Ying S.Y., Leu D., Wu D.T. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 2011, 39:1054-1065.
100. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 2004, 305:1437-1441.
101. Liu X., Fortin K., Mourelatos Z. MicroRNAs: biogenesis and molecular functions. Brain Pathol 2008, 18:113-121.
102. Lu Y., Xiao J., Lin H., Bai Y., Luo X., Wang Z., et al. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res 2009, 37:e24.
103. Ma J.B., Yuan Y.R., Meister G., Pei Y., Tuschl T., Patel D.J. Structural basis for 5'-end-specific recognition of guide RNA by the A. fulgidus Piwi protein. Nature 2005, 434:666-670.
104. Marguerat S., Bahler J. RNA-seq: from technology to biology. Cell Mol Life Sci 2010, 67:569-579.
105. Maroney P.A., Yu Y., Fisher J., Nilsen T.W. Evidence that microRNAs are associated with translating messenger RNAs in human cells. Nat Struct Mol Biol 2006, 13:1102-1107.
106. Marson A., Levine S.S., Cole M.F., Frampton G.M., Brambrink T., Johnstone S., et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008, 134:521-533.
107. Mathonnet G., Fabian M.R., Svitkin Y.V., Parsyan A., Huck L., Murata T., et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 2007, 317:1764-1767.
108. McLaughlin J., Cheng D., Singer O., Lukacs R.U., Radu C.G., Verma I.M., et al. Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics. Proc Natl Acad Sci U S A 2007, 104:20501-20506.
109. Michael M.Z. Cloning microRNAs from mammalian tissues. Methods Mol Biol 2006, 342:189-207.
110. Miluzio A., Beugnet A., Volta V., Biffo S. Eukaryotic initiation factor 6 mediates a continuum between 60S ribosome biogenesis and translation. EMBO Rep 2009, 10:459-465.
111. Minones-Moyano E., Porta S., Escaramis G., Rabionet R., Iraola S., Kagerbauer B., et al. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet 2011, 20:3067-3078.
112. Miska E.A. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005, 15:563-568.
113. Miyoshi N., Ishii H., Nagano H., Haraguchi N., Dewi D.L., Kano Y., et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011, 8:633-638.
114. Morin R.D., O'Connor M.D., Griffith M., Kuchenbauer F., Delaney A., Prabhu A.L., et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 2008, 18:610-621.
115. Mosakhani N., Guled M., Lahti L., Borze I., Forsman M., Paakkonen V., et al. Unique microRNA profile in Dupuytren's contracture supports deregulation of beta-catenin pathway. Mod Pathol 2010, 23:1544-1552.
116. Mourelatos Z., Dostie J., Paushkin S., Sharma A., Charroux B., Abel L., et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 2002, 16:720-728.
117. Müller D., Katinger H., Grillari J. MicroRNAs as targets for engineering of CHO cell factories. Trends Biotechnol 2008, 26:359-365.
118. Naguibneva I., Ameyar-Zazoua M., Polesskaya A., Ait-Si-Ali S., Groisman R., Souidi M., et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 2006, 8:278-284.
119. Najafi-Shoushtari S.H., Kristo F., Li Y., Shioda T., Cohen D.E., Gerszten R.E., et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010, 328:1566-1569.
120. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26:101-106.
121. Nilsen T.W. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 2007, 23:243-249.
122. Nimmo R.A., Slack F.J. An elegant miRror: microRNAs in stem cells, developmental timing and cancer. Chromosoma 2009, 118:405-418.
123. Nottrott S., Simard M.J., Richter J.D. Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nat Struct Mol Biol 2006, 13:1108-1114.
124. Obad S., dos Santos C.O., Petri A., Heidenblad M., Broom O., Ruse C., et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet 2011, 43:371-378.
125. Öhman M. A-to-I editing challenger or ally to the microRNA process. Biochimie 2007, 89:1171-1176.
126. Ono M., Scott M.S., Yamada K., Avolio F., Barton G.J., Lamond A.I. Identification of human miRNA precursors that resemble box C/D snoRNAs. Nucleic Acids Res 2011, 39:3879-3891.
127. Papapetrou E.P., Kovalovsky D., Beloeil L., Sant'angelo D., Sadelain M. Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras. J Clin Invest 2009, 119:157-168.
128. Parker J.S., Roe S.M., Barford D. Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex. Nature 2005, 434:663-666.
129. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
130. Petersen C.P., Bordeleau M.E., Pelletier J., Sharp P.A. Short RNAs repress translation after initiation in mammalian cells. Mol Cell 2006, 21:533-542.
131. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
132. Purow B. The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?. J Neurooncol 2011, 103:429-436.
133. Qiao C., Yuan Z., Li J., He B., Zheng H., Mayer C., et al. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver. Gene Ther 2011, 18:403-410.
134. Rajewsky N. microRNA target predictions in animals. Nat Genet 2006, 38(Suppl.):S8-S13.
135. Ralston A., Rossant J. The genetics of induced pluripotency. Reproduction 2010, 139:35-44.
136. Ranade A.R., Cherba D., Sridhar S., Richardson P., Webb C., Paripati A., et al. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol 2010, 5:1273-1278.
137. Rayner K.J., Suarez Y., Davalos A., Parathath S., Fitzgerald M.L., Tamehiro N., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573.
138. Rehwinkel J., Behm-Ansmant I., Gatfield D., Izaurralde E. A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 2005, 11:1640-1647.
139. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
140. Ro S., Park C., Young D., Sanders K.M., Yan W. Tissue-dependent paired expression of miRNAs. Nucleic Acids Res 2007, 35:5944-5953.
141. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004, 14:1902-1910.
142. Ruby J.G., Jan C.H., Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 2007, 448:83-86.
143. Scherr M., Venturini L., Battmer K., Schaller-Schoenitz M., Schaefer D., Dallmann I., et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 2007, 35:e149.
144. Sehm T., Sachse C., Frenzel C., Echeverri K. miR-196 is an essential early-stage regulator of tail regeneration, upstream of key spinal cord patterning events. Dev Biol 2009, 334:468-480.
145. Seto A.G. The road toward microRNA therapeutics. Int J Biochem Cell Biol 2010, 42:1298-1305.
146. Shafi G., Aliya N., Munshi A. MicroRNA signatures in neurological disorders. Can J Neurol Sci 2010, 37:177-185.
147. Shi Y., Jin Y. MicroRNA in cell differentiation and development. Sci China C Life Sci 2009, 52:205-211.
148. Shyu A.B., Wilkinson M.F., van Hoof A. Messenger RNA regulation: to translate or to degrade. EMBO J 2008, 27:471-481.
149. Sonenberg N. eIF4E, the mRNA cap-binding protein: from basic discovery to translational research. Biochem Cell Biol 2008, 86:178-183.
150. Su H., Trombly M.I., Chen J., Wang X. Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes Dev 2009, 23:304-317.
151. Suarez Y., Fernandez-Hernando C., Yu J., Gerber S.A., Harrison K.D., Pober J.S., et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 2008, 105:14082-14087.
152. Suh M.R., Lee Y., Kim J.Y., Kim S.K., Moon S.H., Lee J.Y., et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004, 270:488-498.
153. Suzuki T., Sakurai F., Nakamura S., Kouyama E., Kawabata K., Kondoh M., et al. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy. Mol Ther 2008, 16:1719-1726.
154. Szczyrba J., Loprich E., Wach S., Jung V., Unteregger G., Barth S., et al. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 2010, 8:529-538.
155. Taft R.J., Glazov E.A., Lassmann T., Hayashizaki Y., Carninci P., Mattick J.S. Small RNAs derived from snoRNAs. RNA 2009, 15:1233-1240.
156. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
157. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
158. Viswanathan S.R., Daley G.Q., Gregory R.I. Selective blockade of microRNA processing by Lin28. Science 2008, 320:97-100.
159. Wakiyama M., Takimoto K., Ohara O., Yokoyama S. Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes Dev 2007, 21:1857-1862.
160. Wang Y., Blelloch R. Cell cycle regulation by microRNAs in embryonic stem cells. Cancer Res 2009, 69:4093-4096.
161. Wang V., Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009, 23:15-23.
162. Wang B., Doench J.G., Novina C.D. Analysis of microRNA effector functions in vitro. Methods 2007, 43:91-104.
163. Wang Y., Baskerville S., Shenoy A., Babiarz J.E., Baehner L., Blelloch R. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 2008, 40:1478-1483.
164. Wang Z., Rao D.D., Senzer N., Nemunaitis J. RNA interference and cancer therapy. Pharm Res 2011, 28:2983-2995.
165. Wark A.W., Lee H.J., Corn R.M. Multiplexed detection methods for profiling microRNA expression in biological samples. Angew Chem Int Ed Engl 2008, 47:644-652.
166. Watanabe Y., Tomita M., Kanai A. Computational methods for microRNA target prediction. Methods Enzymol 2007, 427:65-86.
167. Weber C., Schober A., Zernecke A. MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets 2010, 11:950-956.
168. Wheeler G., Valoczi A., Havelda Z., Dalmay T. In situ detection of animal and plant microRNAs. DNA Cell Biol 2007, 26:251-255.
169. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75:855-862.
170. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009, 11:228-234.
171. Wu X., Ding B., Gao J., Wang H., Fan W., Wang X., et al. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy. Int J Nanomedicine 2011, 6:1747-1756.
172. Xiao J., Yang B., Lin H., Lu Y., Luo X., Wang Z. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 2007, 212:285-292.
173. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
174. Yamakuchi M., Ferlito M., Lowenstein C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 2008, 105:13421-13426.
175. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016.
176. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
177. Zekri L., Huntzinger E., Heimstadt S., Izaurralde E. The silencing domain of GW182 interacts with PABPC1 to promote translational repression and degradation of microRNA targets and is required for target release. Mol Cell Biol 2009, 29:6220-6231.
178. Zhang X., Chen X., Lin J., Lwin T., Wright G., Moscinski L.C., et al. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas. Oncogene 2011, (Electronic publication ahead of print). 10.1038/onc.2011.470.